LINKÖPING, Sweden, June 5, 2024 /PRNewswire/ — International medical imaging IT and cybersecurity company Sectra (STO: SECT-B) reports that all operating areas are growing, and the Group’s sales for the fourth quarter surpassed earlier record-breaking levels. Cloud recurring revenue (CRR) is growing the fastest, which shows that the transition to delivering services is progressing at a rapid rate. It is proposed that the 2024 Annual General Meeting (AGM) resolve that SEK 1.10 per share be distributed to the shareholders through a share redemption program.
2023/2024 fiscal year
Fourth quarter: February–April 2024
Comments from Torbjörn Kronander, President and CEO of Sectra AB
“At Sectra, we prioritize long-term earnings performance over short-term margin increases. The long-term perspective and close customer relationships have resulted in a solid performance throughout the years, and 2023/2024 is no exception. Among other achievements, we won several long-term, major customer contracts in both secure communications and medical IT.
Sectra is in the middle of a major transition of the business model in its largest operating area, Imaging IT Solutions. We are moving from license sales to service sales, which means that revenue will be spread out over a longer period of time. In the short term, this will affect growth in both sales and profit. Despite this, the outcome for the year was good, driven largely by our success in the US and the UK and by major improvements in Secure Communications. All business areas are growing, with positive earnings.
I’m proud of what we’ve accomplished so far and would like to express my appreciation to all of our customers, employees, partners and shareholders for the confidence and support you are giving Sectra. Together, we are creating value both for individual patients and for government officials as well as for society as a whole.”
Read the attached year-end report for further CEO comments and information.
Presentation of the year-end report
Torbjörn Kronander, President and CEO of Sectra AB, and Jessica Holmquist, CFO of Sectra AB, will present the financial report and answer questions. The presentation will be held in English.
Time: June 5, 2024, at 10:00 a.m. CEST
Follow live or listen to the recording afterward: https://investor.sectra.com/q4report2324
This information constitutes information that Sectra AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and/or the Swedish Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 8:15 a.m. CEST on June 5, 2024.
For further information, please contact:
Dr. Torbjörn Kronander, President and CEO, Sectra AB, +46 (0) 705 23 52 27
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Sectra’s Year-end Report 2023/2024 |
|
https://news.cision.com/sectra/i/torbjorn-kronander–ceo-and-president-sectra-ab,c3306192 |
Torbjörn Kronander, CEO and President Sectra AB |
Sectra Tiger/S |
|
https://news.cision.com/sectra/i/sectra-s-digital-pathology-solution,c3306191 |
Sectra’s digital pathology solution |
SOURCE Sectra
Hemogenyx Pharmaceuticals Receives IRB Approval for Phase 1 Clinical Trial of HEMO-CAR-T (HG-CT-1)LONDON, UK /…
SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular…
BEVERLY HILLS, CALIFORNIA / ACCESSWIRE / November 21, 2024 / Nicole Garrett, CEO of Under…
HUNTINGTON BEACH, Calif., Nov. 21, 2024 /PRNewswire/ -- Beacon Healthcare Systems, is pleased to announce…
Attributes Revenue Growth to Innovative Partnerships, Strong Team, and Unique Value-Based Care Model NEW YORK,…
Automation That Makes a Difference SUNRISE, Fla., Nov. 21, 2024 /PRNewswire/ -- When it comes…